Complete financial analysis of Horizon Technology Finance Corporation (HRZN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Horizon Technology Finance Corporation, a leading company in the Asset Management industry within the Financial Services sector.
- The Toronto-Dominion Bank (TNTTF) Income Statement Analysis – Financial Results
- MKD Technology Inc. (MKDWW) Income Statement Analysis – Financial Results
- AddTech Hub Public Company Limited (ADD.BK) Income Statement Analysis – Financial Results
- Talon Metals Corp. (TLO.TO) Income Statement Analysis – Financial Results
- Arion Group Corp. (ARGC) Income Statement Analysis – Financial Results
Horizon Technology Finance Corporation (HRZN)
About Horizon Technology Finance Corporation
Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries. It seeks to invest in companies in the United States.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | -9.87M | 26.64M | 33.27M | 10.33M | 21.30M | 14.90M | 12.40M | -1.76M | 14.97M | 20.85M | 7.23M | 7.32M | 14.78M | 15.33M | 16.36M |
Cost of Revenue | 0.00 | 19.98M | 15.96M | 12.66M | 11.58M | -11.61M | 6.12M | 7.72M | 7.90M | 0.00 | 0.00 | -15.14M | 4.19M | 0.00 | 2.20M |
Gross Profit | -9.87M | 6.66M | 17.31M | -2.33M | 9.72M | 26.51M | 6.28M | -9.48M | 7.06M | 20.85M | 7.23M | 22.46M | 10.59M | 15.33M | 14.15M |
Gross Profit Ratio | 100.00% | 25.01% | 52.03% | -22.54% | 45.63% | 177.93% | 50.66% | 539.00% | 47.20% | 100.00% | 100.00% | 306.73% | 71.64% | 100.00% | 86.54% |
Research & Development | 0.00 | 0.30 | 0.49 | 0.20 | 0.50 | 0.41 | 2.10 | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 5.67M | 4.78M | 4.69M | 3.75M | 3.41M | 3.04M | 2.87M | 3.24M | 3.46M | 5.26M | 3.48M | 3.10M | 3.45M | 321.00K | 321.51K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 5.67M | 4.78M | 4.69M | 3.75M | 3.41M | 3.04M | 2.87M | 3.24M | 3.46M | 5.26M | 3.48M | 3.10M | 3.45M | 321.00K | 321.51K |
Other Expenses | 0.00 | -9.38M | 395.00K | -2.64M | -1.85M | -6.36M | -5.17M | -5.88M | -3.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 274.38K |
Operating Expenses | 21.57M | 4.78M | 5.08M | 3.75M | 1.56M | 1.86M | 2.79M | 3.24M | 3.11M | 5.26M | 3.48M | 3.10M | 3.45M | 321.00K | 595.89K |
Cost & Expenses | 21.57M | 4.78M | 5.08M | 3.75M | 1.56M | 1.86M | 2.79M | 3.24M | 3.11M | 5.26M | 3.48M | 3.10M | 10.65M | 321.00K | 2.80M |
Interest Income | 110.13M | 77.37M | 54.41M | 42.19M | 37.09M | 28.79M | 23.76M | 31.40M | 28.65M | 28.64M | 31.90M | 25.29M | 22.97M | 14.99M | 4.24M |
Interest Expense | 28.97M | 19.20M | 12.03M | 9.67M | 8.33M | 6.36M | 5.17M | 5.88M | 5.76M | 8.71M | 8.12M | 4.28M | 2.68M | 4.25M | 4.24M |
Depreciation & Amortization | 0.00 | 29.35M | 16.56M | 15.30M | 11.12M | 18.73M | -5.03M | 30.21M | 5.76M | 8.71M | 8.12M | 4.28M | -2.40M | 0.00 | 0.00 |
EBITDA | 11.94M | 0.00 | 0.00 | 0.00 | 0.00 | 19.41M | 9.62M | 22.89M | 0.00 | -3.99M | -9.76M | 16.51M | 14.64M | 14.73M | 13.56M |
EBITDA Ratio | -120.93% | 154.15% | 84.72% | 63.74% | 92.66% | 128.05% | 140.36% | -1,301.31% | 131.99% | 93.95% | 299.28% | 225.52% | 94.82% | 97.91% | 82.89% |
Operating Income | -1.34M | 41.07M | 28.18M | 6.59M | 19.74M | 24.66M | 12.32M | 17.01M | 14.00M | 10.88M | 13.51M | 12.23M | 16.42M | 15.01M | 13.56M |
Operating Income Ratio | 13.56% | 154.15% | 84.72% | 63.74% | 92.66% | 165.48% | 99.34% | -967.14% | 93.52% | 52.18% | 186.90% | 167.01% | 111.05% | 97.91% | 82.89% |
Total Other Income/Expenses | -14.36M | -23.09M | -7.54M | -8.34M | -6.07M | -6.04M | -7.87M | -22.01M | -7.90M | -3.99M | -17.89M | -12.29M | -2.07M | 0.00 | -4.24M |
Income Before Tax | -15.70M | 21.87M | 28.18M | 6.59M | 19.74M | 13.04M | 9.62M | -5.00M | 11.86M | 15.59M | 3.75M | 4.22M | 11.34M | 0.00 | 9.31M |
Income Before Tax Ratio | 159.00% | 82.07% | 84.72% | 63.74% | 92.66% | 87.54% | 77.52% | 284.25% | 79.22% | 74.79% | 51.85% | 57.67% | 76.69% | 0.00% | 56.94% |
Income Tax Expense | 1.49M | 715.00K | 401.00K | 222.00K | 239.00K | 34.00K | 25.00K | -87.00K | 0.00 | 160.00K | 240.00K | 231.00K | 340.00K | 0.00 | -9.31M |
Net Income | -17.19M | 21.15M | 27.78M | 6.36M | 19.50M | 13.01M | 9.59M | -4.91M | 11.86M | 15.43M | 3.51M | 3.99M | 11.00M | 0.00 | 9.31M |
Net Income Ratio | 174.10% | 79.39% | 83.51% | 61.60% | 91.54% | 87.32% | 77.32% | 279.31% | 79.22% | 74.02% | 48.53% | 54.51% | 74.39% | 0.00% | 56.94% |
EPS | -0.56 | 0.86 | 1.39 | 0.36 | 1.45 | 1.13 | 0.83 | -0.43 | 1.06 | 1.60 | 0.37 | 0.47 | 1.44 | 0.00 | 1.23 |
EPS Diluted | -0.56 | 0.86 | 1.39 | 0.36 | 1.45 | 1.13 | 0.83 | -0.43 | 1.06 | 1.60 | 0.37 | 0.47 | 1.44 | 0.00 | 1.23 |
Weighted Avg Shares Out | 30.96M | 24.73M | 20.03M | 17.53M | 13.48M | 11.53M | 11.52M | 11.54M | 11.18M | 9.62M | 9.58M | 8.48M | 7.61M | 0.00 | 7.56M |
Weighted Avg Shares Out (Dil) | 30.96M | 24.73M | 20.03M | 17.53M | 13.48M | 11.53M | 11.52M | 11.54M | 11.18M | 9.62M | 9.58M | 8.48M | 7.61M | 0.00 | 7.56M |
Horizon Technology Finance Announces Monthly Distributions for January, February and March 2024 Totaling $0.33 per Share and Special Distribution for December 2023 of $0.05 per Share
Horizon Technology Finance Announces Third Quarter 2023 Financial Results
Horizon Technology Finance to Announce Third Quarter 2023 Financial Results
Horizon Technology Finance Provides Third Quarter 2023 Portfolio Update
Horizon Technology Finance Provides $35 Million Venture Loan Facility to Mirantis
Horizon Technology Finance Provides $40 Million Venture Loan Facility to Elligo Health Research
11%-Yielding Horizon Technology: A Smart Monthly Payer To Buy
Horizon Technology Finance: 10% Tech And Life Science Yield, Monthly Payer
Horizon Technology Finance Management Expands Origination Team
SONEX HEALTH CLOSES SERIES B FINANCING TO EXPAND PHYSICIAN AND PATIENT ACCESS TO MINIMALLY INVASIVE TREATMENT FOR CARPAL TUNNEL SYNDROME
Source: https://incomestatements.info
Category: Stock Reports